Cart
sales@molnova.com
ARRY380
CAS No. 937265-83-3
ARRY380 ( ARRY-380 analog; ONT380 analog; ONT 380 analog; ONT-380 analog )
Catalog No. M16714 CAS No. 937265-83-3
ARRY-380 is a potent and selective HER2 inhibitor with IC50 of 8 nM.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 63 | In Stock |
|
| 5MG | 105 | In Stock |
|
| 10MG | 168 | In Stock |
|
| 25MG | 284 | In Stock |
|
| 50MG | 422 | In Stock |
|
| 100MG | 618 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameARRY380
-
NoteResearch use only, not for human use.
-
Brief DescriptionARRY-380 is a potent and selective HER2 inhibitor with IC50 of 8 nM.
-
DescriptionARRY-380 is a potent and selective HER2 inhibitor with IC50 of 8 nM, equipotent against truncated p95-HER2, 500-fold more selective for HER2 versus EGFR.
-
SynonymsARRY-380 analog; ONT380 analog; ONT 380 analog; ONT-380 analog
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR; HER2; p95-HER2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number937265-83-3
-
Formula Weight569.63
-
Molecular FormulaC29H27N7O4S
-
Purity>98%(HPLC)
-
SolubilityDMSO: > 10mM
-
SMILESCC1=C(OC2=CC3=NC=NN3C=C2)C=CC(NC2=NC=NC3=C2C=C(C=C3)C2=CC=C(CNCCS(C)(=O)=O)O2)=C1
-
Chemical Name6-[5-[[[2-(Methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-4-quinazolinamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Madala SK, et al. Am J Respir Cell Mol Biol. 2012 Mar;46(3):380-8.
molnova catalog
related products
-
Gefitinib hydrochlor...
A potent, selective, orally active EGFR inhibitor with IC50 of 23 nM.
-
Tarloxotinib bromide
Tarloxotinib bromide is an irreversible inhibitor of EGFR/HER2.
-
Lifirafenib
Lifirafenib is a potent inhibitor of RAF family kinases and EGFR in biochemical assays with IC50 of 23, 29 and 495 nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant respectively.
